Frequently asked questions What is the BPC-157 + TB-500 blend?+ It is a combined research preparation of two tissue-repair peptides, BPC-157 and TB-500, supplied together for in-vitro study
Whether you're making mochi, rice cakes, or using it in baking, this extra-fine flour offers a delicious and nutritious alternative to standard flours
the oral option Foundayo is already FDA-approved and available for patients who want to avoid injections entirely Who Faces the Greatest Benefit From Extended-Dosing Options Based on current research on GLP-1 adherence challenges: Patients with needle phobia or injection anxiety who have delayed starting GLP-1 therapy Patients who report forgetting their weekly injection or injecting on the wrong day People with irregular weekly schedules including shift workers, frequent travelers, and caregivers for whom a consistent weekly schedule is difficult to maintain Patients who stopped weekly GLP-1 therapy specifically because of the injection burden An oral pill eliminates injection entirely and is already available through Foundayo for eligible patients

Asia Pacific Glutathione Market Trends Asia Pacific is positioned to emerge as the fastest-growing regional market for glutathione consumption, driven by expanding health consciousness and consumer interest in beauty and wellness across major markets including China, Japan, India, and South Korea